Literature DB >> 12643183

Cardiovascular risk factors in diabetic patients with hypertension.

Nathaniel Winer1, James R Sowers.   

Abstract

Individuals with diabetes mellitus have cardiovascular disease (CVD) mortality comparable to nondiabetics who have suffered a myocardial infarction or stroke. Aggressive management of risk factors such as hypertension, dyslipidemia, and platelet dysfunction in persons with diabetes has been shown to reduce morbidity and mortality in prospective randomized controlled clinical trials. Accordingly, there are national mandates to lower blood pressure to less than 130/85 mm Hg, reduce low-density lipoprotein cholesterol to less than 100 mg/dL, and institute aspirin therapy in adult patients with diabetes. Although not definitively shown to reduce CVD, there are also recommendations to control the level of glycemia, as well. This article discusses CVD risk factors in the diabetic patient with hypertension.

Entities:  

Mesh:

Year:  2002        PMID: 12643183     DOI: 10.1007/s11892-002-0093-3

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  30 in total

1.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

Review 2.  Diabetes, hypertension, and cardiovascular disease: an update.

Authors:  J R Sowers; M Epstein; E D Frohlich
Journal:  Hypertension       Date:  2001-04       Impact factor: 10.190

3.  Treatment of Elderly Hypertensive Patients With Diabetes, Renal Disease, and Coronary Heart Disease.

Authors:  James R. Sowers; Stephen L. Farrow
Journal:  Am J Geriatr Cardiol       Date:  1996-10

4.  Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators.

Authors:  J Tuomilehto; D Rastenyte; W H Birkenhäger; L Thijs; R Antikainen; C J Bulpitt; A E Fletcher; F Forette; A Goldhaber; P Palatini; C Sarti; R Fagard
Journal:  N Engl J Med       Date:  1999-03-04       Impact factor: 91.245

5.  Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators.

Authors: 
Journal:  Lancet       Date:  2000-01-22       Impact factor: 79.321

6.  Comorbidity of hypertension and diabetes: the fosinopril versus amlodipine cardiovascular events trial (FACET)

Authors:  J R Sowers
Journal:  Am J Cardiol       Date:  1998-11-12       Impact factor: 2.778

Review 7.  Obesity and cardiovascular disease.

Authors:  J R Sowers
Journal:  Clin Chem       Date:  1998-08       Impact factor: 8.327

8.  Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

Authors:  M Ravid; R Lang; R Rachmani; M Lishner
Journal:  Arch Intern Med       Date:  1996-02-12

Review 9.  Hyperglycemia and microvascular and macrovascular disease in diabetes.

Authors:  R Klein
Journal:  Diabetes Care       Date:  1995-02       Impact factor: 19.112

Review 10.  Health care for persons with non-insulin-dependent diabetes mellitus. The German experience.

Authors:  M Berger; V Jörgens; G Flatten
Journal:  Ann Intern Med       Date:  1996-01-01       Impact factor: 25.391

View more
  1 in total

1.  Can a chronic care model collaborative reduce heart disease risk in patients with diabetes?

Authors:  Roberto B Vargas; Carol M Mangione; Steven Asch; Joan Keesey; Mayde Rosen; Matthias Schonlau; Emmett B Keeler
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.